Based on 6 reviews
Daten Capital LLP is a private limited liability partnership that uses data science to drive capital allocation, with an initial focus on estimating drug trial success rates in the biotech sector primarily in the US and Europe. The firm is backed by leading corporates and investors in the healthcare and technology sectors, and its affiliated biotech hedge fund launched in May 2019.
The reviews on file do not identify any recurring complaints about Daten Capital; only one 3-star review exists, and its excerpt focuses on a positive experience with the company rather than a specific grievance.
AI-generated from reviews on this page. Verify anything important with the company directly.
I want to express my gratitude to Daten Capital for the exceptional service they provided. From the moment I reached out to them, I was impressed with their professionalism and efficiency. They listened to my needs and delivered a customized solution that exceeded my expectations. I highly recommend their services.
I recently used a financial service provider and I was not satisfied with their performance. However, I decided to give Daten Capital a chance and I'm glad I did. They exceeded my expectations in every way. Their staff was professional, knowledgeable, and provided excellent customer service.
👍 I am so glad I found Daten Capital! They provided me with outstanding financial services that were tailored to my needs. The team was responsive and knowledgeable. I highly recommend their services to anyone in need of financial assistance. 👏
I had a positive experience with a company that provides financial services. They have a user-friendly website and their team is very professional. I would highly recommend their services.
I had a great experience working with Daten Capital. Their team was professional and efficient in handling my financial needs. They provided me with valuable advice and helped me achieve my financial goals. I highly recommend their services.
I had a great experience with Daten Capital! Their website was easy to navigate and I was able to find all the information I needed. The team was very helpful and responsive to all my questions. I highly recommend working with them.
No news yet. This is where the business shares its own updates and press.
No photos yet. Photos shared by reviewers will show up here.
Daten Capital LLP is a private limited liability partnership, leveraging data science to drive capital allocation. The firm's initial focus will be on the biotech sector, primarily in the US and Europe. Daten will utilise exclusive industry data and analytics to estimate drug trial success rates. The firm is backed by leading corporates and investors in the healthcare and technology sectors. The affiliated biotech hedge fund launched in May 2019.